Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121072022 | 12107202 | 2 | F | 20120408 | 20160621 | 20160223 | 20160705 | EXP | US-ACORDA-ACO_114091_2015 | ACORDA | 63.65 | YR | F | Y | 41.72000 | KG | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121072022 | 12107202 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | U | U | SDYZ | 22250 | 10 | MG | TABLET | BID | |||
| 121072022 | 12107202 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | UNK | U | U | 22250 | TABLET | ||||||||
| 121072022 | 12107202 | 3 | SS | TECFIDERA | DIMETHYL FUMARATE | 1 | Oral | 240 MG, BID | U | 0 | 240 | MG | BID | ||||||
| 121072022 | 12107202 | 4 | C | TRAMADOL. | TRAMADOL | 1 | Unknown | 50 MG, TID | U | 0 | 50 | MG | TID | ||||||
| 121072022 | 12107202 | 5 | C | BACLOFEN. | BACLOFEN | 1 | Unknown | 20 MG, 1 IN THE MORNING, 2 IN THE AFTERNOON AND 2 AT BEDTIME | U | 0 | 20 | MG | |||||||
| 121072022 | 12107202 | 6 | C | Oxybutynin | OXYBUTYNIN | 1 | Unknown | 15 MG, BID | U | 0 | 15 | MG | BID | ||||||
| 121072022 | 12107202 | 7 | C | COPAXONE | GLATIRAMER ACETATE | 1 | Unknown | 40 MG, 3X/WK | U | 0 | 40 | MG | TIW | ||||||
| 121072022 | 12107202 | 8 | C | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 2 MG, 1/2 TAB AT BEDTIME | U | 0 | 2 | MG | |||||||
| 121072022 | 12107202 | 9 | C | Pantoprazole | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 121072022 | 12107202 | 10 | C | KLONOPIN | CLONAZEPAM | 1 | Unknown | 0.5 MG, 1/2 TAB AT BEDTIME | U | 0 | .5 | MG | |||||||
| 121072022 | 12107202 | 11 | C | NIFEDIPINE. | NIFEDIPINE | 1 | Unknown | 60 MG, QD | U | 0 | 60 | MG | QD | ||||||
| 121072022 | 12107202 | 12 | C | NITROFURANTOIN. | NITROFURANTOIN | 1 | Unknown | 50 MG, QD | U | 0 | 50 | MG | QD | ||||||
| 121072022 | 12107202 | 13 | C | LYRICA | PREGABALIN | 1 | Unknown | 50 MG, 1 IN THE AFTERNOON AND 4 AT BEDTIME | U | 0 | 50 | MG | |||||||
| 121072022 | 12107202 | 14 | C | MYRBETRIQ | MIRABEGRON | 1 | Unknown | 25 MG, QD | U | 0 | 25 | MG | QD | ||||||
| 121072022 | 12107202 | 15 | C | COLACE | DOCUSATE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 121072022 | 12107202 | 16 | C | Glucosamine + Chondroitin | 2 | Unknown | UNK | U | 0 | ||||||||||
| 121072022 | 12107202 | 17 | C | Therapeutic multivitamin | 2 | Unknown | UNK UNK, QD | U | 0 | QD | |||||||||
| 121072022 | 12107202 | 18 | C | Magnesium | MAGNESIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 121072022 | 12107202 | 19 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 1000 IU, UNK | U | 0 | 1000 | IU | |||||||
| 121072022 | 12107202 | 20 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 121072022 | 12107202 | 21 | C | SENOKOT | SENNOSIDES | 1 | Unknown | UNK | U | 0 | |||||||||
| 121072022 | 12107202 | 22 | C | Other therapeutic products | UNSPECIFIED INGREDIENT | 1 | Unknown | UNK | U | 0 | |||||||||
| 121072022 | 12107202 | 23 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 121072022 | 12107202 | 24 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121072022 | 12107202 | 1 | Gait disturbance |
| 121072022 | 12107202 | 3 | Multiple sclerosis |
| 121072022 | 12107202 | 4 | Product used for unknown indication |
| 121072022 | 12107202 | 5 | Product used for unknown indication |
| 121072022 | 12107202 | 6 | Product used for unknown indication |
| 121072022 | 12107202 | 7 | Product used for unknown indication |
| 121072022 | 12107202 | 8 | Product used for unknown indication |
| 121072022 | 12107202 | 9 | Product used for unknown indication |
| 121072022 | 12107202 | 10 | Product used for unknown indication |
| 121072022 | 12107202 | 11 | Product used for unknown indication |
| 121072022 | 12107202 | 12 | Product used for unknown indication |
| 121072022 | 12107202 | 13 | Product used for unknown indication |
| 121072022 | 12107202 | 14 | Product used for unknown indication |
| 121072022 | 12107202 | 15 | Product used for unknown indication |
| 121072022 | 12107202 | 16 | Product used for unknown indication |
| 121072022 | 12107202 | 17 | Product used for unknown indication |
| 121072022 | 12107202 | 18 | Product used for unknown indication |
| 121072022 | 12107202 | 19 | Product used for unknown indication |
| 121072022 | 12107202 | 20 | Product used for unknown indication |
| 121072022 | 12107202 | 21 | Product used for unknown indication |
| 121072022 | 12107202 | 22 | Product used for unknown indication |
| 121072022 | 12107202 | 23 | Product used for unknown indication |
| 121072022 | 12107202 | 24 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121072022 | 12107202 | DE |
| 121072022 | 12107202 | HO |
| 121072022 | 12107202 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121072022 | 12107202 | Asthenia | |
| 121072022 | 12107202 | Bronchiectasis | |
| 121072022 | 12107202 | Insomnia | |
| 121072022 | 12107202 | Lymphocyte count decreased | |
| 121072022 | 12107202 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121072022 | 12107202 | 1 | 2011 | 0 | ||
| 121072022 | 12107202 | 3 | 201307 | 201502 | 0 |